Skip to main content
Clinical Trials/NCT02425475
NCT02425475
Completed
Not Applicable

A Prospective, Non-controlled, Multicenter Clinical Study to Evaluate the Diagnostic Accuracy of the Stepwise Two Photon Excited Melanin Fluorescence of Potentially Malignant Pigmented Lesions as Compared to Histopathological Diagnosis

University Hospital Tuebingen2 sites in 1 country500 target enrollmentAugust 2014
ConditionsMelanomaMoles

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Melanoma
Sponsor
University Hospital Tuebingen
Enrollment
500
Locations
2
Primary Endpoint
To determine sensitivity and specificity of the algorithm for the fluorescence diagnostics of melanoma.
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

All patients will undergo dermoscopic diagnosis and be documented with a video image storing. The diagnosis based on dermoscopy will be immediately documented. Then, as a second diagnostic procedure, fluorescence diagnostics based on the two photon excitation from a dye-laser will be performed. The classification as non-melanoma or malignant melanoma by the medical device LIMES will also be documented immediately. Afterwards, the lesion will be excised and undergo histopathologic examination by the respective histopathologist of the participating centers. The histopathologic diagnosis will serve as gold standard for subsequent evaluations of the diagnostic accuracy.

Registry
clinicaltrials.gov
Start Date
August 2014
End Date
December 2016
Last Updated
9 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patients ≥ 18 years of age
  • Male or female
  • Patients having pigmented lesions with suspicion of dysplastic nevus or melanoma, in whom an excision is performed in order to exclude or diagnose malignant melanoma
  • Patients who gave their written informed consent.

Exclusion Criteria

  • Patients with skin type V and VI according to Fitzpatrick's scale;
  • Where there is a risk that the scanning head is torn off be-cause the patient cannot be placed at rest (e.g. due to motoric disorders like tremor, convulsions, tics, compulsive acts
  • Patients who cannot understand the patient information and provide informed consent
  • Deep dermal lesions ≥ 5 mm beneath the stratum corneum
  • Clinically or reflected-light microscopically obviously non-melanocytic lesions
  • Peri- and subungual lesions
  • Mucosal lesions
  • Lesions with trauma, erosion (superficial defect), excoriation (defect down to the basement membrane) or ulceration (deep substantial defect) on more than 50 % of the lesion area (measurements must in any case not be carried out directly on the trauma, erosion, excoriation or ulceration)
  • Tattooed lesions
  • Pregnant or breast feeding women

Outcomes

Primary Outcomes

To determine sensitivity and specificity of the algorithm for the fluorescence diagnostics of melanoma.

Time Frame: 7 days

The comparator and gold standard for the diagnosis will be the histopathological diagnosis of the pigmented lesions.

Secondary Outcomes

  • To collect data for training and optimization of the diagnostic algorithm.(1 day)

Study Sites (2)

Loading locations...

Similar Trials